The Moving Average Convergence Divergence (MACD) for INBS turned positive on October 16, 2026. Looking at past instances where INBS's MACD turned positive, the stock continued to rise in 35 of 38 cases over the following month. The odds of a continued upward trend are 90%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where INBS's RSI Oscillator exited the oversold zone, 40 of 46 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 60 of 70 cases where INBS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.
Following a +6.25% 3-day Advance, the price is estimated to grow further. Considering data from situations where INBS advanced for three days, in 153 of 182 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
INBS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The 10-day moving average for INBS crossed bearishly below the 50-day moving average on September 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INBS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for INBS entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.921) is normal, around the industry mean (2.908). P/E Ratio (-0.181) is within average values for comparable stocks, (2.616). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.688) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. INBS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INBS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
The Aroon Indicator for NVNO entered a downward trend on September 25, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 255 similar instances where the Aroon Indicator formed such a pattern. In 226 of the 255 cases the stock moved lower. This puts the odds of a downward move at 89%.
The 10-day moving average for NVNO crossed bearishly below the 50-day moving average on September 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVNO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where NVNO's RSI Indicator exited the oversold zone, 30 of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for NVNO just turned positive on October 19, 2026. Looking at past instances where NVNO's MACD turned positive, the stock continued to rise in 32 of 45 cases over the following month. The odds of a continued upward trend are 71%.
Following a +4.25% 3-day Advance, the price is estimated to grow further. Considering data from situations where NVNO advanced for three days, in 191 of 252 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
NVNO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.261) is normal, around the industry mean (2.908). P/E Ratio (-0.311) is within average values for comparable stocks, (2.616). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. NVNO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVNO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
INBS | NVNO | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 56 | 83 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 49 Fair valued | 40 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 98 | |
PRICE GROWTH RATING 1..100 | 50 | 50 | |
P/E GROWTH RATING 1..100 | 20 | 18 | |
SEASONALITY SCORE 1..100 | 50 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NVNO's Valuation (40) in the null industry is in the same range as INBS (49). This means that NVNO’s stock grew similarly to INBS’s over the last 12 months.
NVNO's Profit vs Risk Rating (100) in the null industry is in the same range as INBS (100). This means that NVNO’s stock grew similarly to INBS’s over the last 12 months.
NVNO's SMR Rating (98) in the null industry is in the same range as INBS (100). This means that NVNO’s stock grew similarly to INBS’s over the last 12 months.
NVNO's Price Growth Rating (50) in the null industry is in the same range as INBS (50). This means that NVNO’s stock grew similarly to INBS’s over the last 12 months.
NVNO's P/E Growth Rating (18) in the null industry is in the same range as INBS (20). This means that NVNO’s stock grew similarly to INBS’s over the last 12 months.
| INBS | NVNO | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 87% | 2 days ago 75% |
| Stochastic ODDS (%) | 2 days ago 86% | 2 days ago 81% |
| Momentum ODDS (%) | N/A | N/A |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 71% |
| TrendWeek ODDS (%) | 2 days ago 83% | 2 days ago 85% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 83% |
| Advances ODDS (%) | 2 days ago 84% | 14 days ago 76% |
| Declines ODDS (%) | 6 days ago 90% | 7 days ago 85% |
| BollingerBands ODDS (%) | 7 days ago 90% | 2 days ago 74% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 89% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
INBS’s FA Score shows that 1 FA rating(s) are green while NVNO’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
INBS’s TA Score shows that 5 TA indicator(s) are bullish while NVNO’s TA Score has 5 bullish TA indicator(s).
INBS (@Medical/Nursing Services) experienced а +0.66% price change this week, while NVNO (@Medical/Nursing Services) price change was -6.39% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -3.67%. For the same industry, the average monthly price growth was -9.97%, and the average quarterly price growth was -11.02%.
INBS is expected to report earnings on Nov 05, 2026.
NVNO is expected to report earnings on Nov 05, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, INBS has been loosely correlated with IVF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if INBS jumps, then IVF could also see price increases.
| Ticker / NAME | Correlation To INBS | 1D Price Change % | ||
|---|---|---|---|---|
| INBS | 100% | +2.00% | ||
| IVF - INBS | 63% Loosely correlated | +4.23% | ||
| ELMD - INBS | 31% Poorly correlated | -0.07% | ||
| NVNO - INBS | 27% Poorly correlated | +4.02% | ||
| ITGR - INBS | 27% Poorly correlated | +0.04% | ||
| PFSA - INBS | 26% Poorly correlated | -3.32% | ||
More | ||||
A.I.dvisor tells us that NVNO and HBIO have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVNO and HBIO's prices will move in lockstep.
| Ticker / NAME | Correlation To NVNO | 1D Price Change % | ||
|---|---|---|---|---|
| NVNO | 100% | +4.02% | ||
| HBIO - NVNO | 31% Poorly correlated | N/A | ||
| DHR - NVNO | 31% Poorly correlated | -2.01% | ||
| RGEN - NVNO | 30% Poorly correlated | +0.58% | ||
| TWST - NVNO | 30% Poorly correlated | +5.29% | ||
| RDNT - NVNO | 28% Poorly correlated | +0.68% | ||
More | ||||